This project is supported by the Japan Agency for Medical Research and Development (AMED).

2024~2026 Program for Accelerating the Realization of Regenerative/Cell Medicine and Gene Therapy (Regenerative/Cell Medicine and Gene Therapy Research and Development Proposals (Non-clinical PoC Acquisition Proposals))

subject for study (inquiry, enquiry) Development of in vivo cell fate transformation technology for innovative radical cure of severe type 1 diabetes

link to site

top